Linuo Medicine Pack: Some products have already been supplied to pharmaceutical companies in Europe and America. We will actively seek to enter the supply chain of more global mainstream pharmaceutical companies.

Lino medicine package stated on the interactive platform on April 20 that, against the backdrop of adjustments in the global pharmaceutical supply chain layout, the company has actively expanded into international markets, and some products have already been supplied to pharmaceutical companies in Europe and the United States. With continuously improving product quality, technological strength, and supply chain reliability, the company will continue to promote its internationalization strategy and actively seek to enter the supplier systems of more global mainstream pharmaceutical companies. By 2025, the company will have built and put into production RTU products, with a focus on sales in the United States.